You are here:

Combretastatin-induced hypertension and the consequences for its combination with other therapies.

Busk M et al. Vascul Pharmacol. 2011 Jan-Feb;54(1-2):13-7.

Busk M, Bohn AB, Skals M, Wang T, Horsman MR.
Vascular pharmacology
Vascul Pharmacol. 2011 Jan-Feb;54(1-2):13-7.
21040805

Link PubMed